Show simple item record

dc.creatorGrobler, Anna Christina.
dc.creatorAbdool Karim, Salim Safurdeen.
dc.date.accessioned2013-06-25T07:34:44Z
dc.date.available2013-06-25T07:34:44Z
dc.date.created2012
dc.date.issued2012-11-13
dc.identifier.citationGrobler, A., Abdool Karim, S.S. 2012. Declining adherence is a more likely explanation than frailty of the apparent decline in efficacy in the CAPRISA 004 trial: response to O’Hagan et al. AIDS 26 (17) p.2261.en
dc.identifier.issn0269-9370
dc.identifier.urihttp://dx.doi.org/10.1097/QAD.0b013e328355ce08en
dc.identifier.urihttp://hdl.handle.net/10413/9195
dc.description.abstractNo abstract available.en
dc.language.isoenen
dc.publisherLippincott Williams & Wilkins.en
dc.subjectClinical trials--Evaluation.en
dc.subjectHIV infections--Treatment.en
dc.subjectHIV infections--Drug therapy.en
dc.subjectPatient compliance.en
dc.subject.otherCAPRISA 004 microbicide trial.en
dc.subject.otherDrug adherence.en
dc.titleDeclining adherence is a more likely explanation than frailty of the apparent decline in efficacy in the CAPRISA 004 trial: response to O’Hagan et al.en
dc.typePeer reviewed journal articleen


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record